Essential molecular markers, in addition to IDH mutations, include alpha-thalassemia/mental retardation syndrome X-linked (ATRX) loss and p53 expression, which significantly influence their classification and prognosis. The gene discussed is TP53; the disease is alpha thalassemia spectrum.